Brian C. Broderick’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,849	Closed	-$219K	–	93
2016 Q4	$219K	Sell	5,849 -20	-0.3%	-$837	0.09%	90
2016 Q3	$398K	Sell	5,869 -113	-2%	-$7.97K	0.17%	78
2016 Q2	$331K	Buy	5,982 +1,010	+20%	+$63.6K	0.14%	84
2016 Q1	$313K	Buy	4,972 +47	+1%	+$3.13K	0.14%	87
2015 Q4	$464K	Buy	4,925 +40	+0.8%	+$3.71K	0.21%	75
2015 Q3	$393K	Sell	4,885 -102	-2%	-$11.3K	0.18%	76
2015 Q2	$597K	Sell	4,987 -40	-0.8%	-$4.78K	0.25%	69
2015 Q1	$525K	Buy	5,027 +325	+7%	+$32.9K	0.22%	71
2014 Q4	$457K	Sell	4,702 -151	-3%	-$14K	0.19%	74
2014 Q3	$380K	Sell	4,853 -25	-0.5%	-$1.61K	0.17%	79
2014 Q2	$309K	Buy	4,878 +120	+3%	+$7.13K	0.14%	84
2014 Q1	$320K	Sell	4,758 -4,662	-49%	-$361K	0.16%	77
2013 Q4	$606K	Sell	9,420 -235	-2%	-$14K	0.3%	65
2013 Q3	$618K	Sell	9,655 -275	-3%	-$13.7K	0.34%	63
2013 Q2	$308K	Buy	+9,930	New	+$264K	0.18%	76